Andreas Bernkop-Schnürch

Andreas Bernkop-Schnürch (born in Klagenfurt, December 6, 1965) is an Austrian scientist and entrepreneur, who is Head of the Department of Pharmaceutical Technology in the Institute of Pharmacy at the University of Innsbruck.

His research centers on the areas of drug delivery, dosage forms, controlled release, bionanotechnology, polymer engineering and tissue engineering. He is the inventor of several technologies, such as thiolated polymers, for which he coined the name thiomers in 2000, and phosphatase triggered charge-converting nanoparticles for mucosal drug delivery.

Bernkop-Schnürch has been on the scientific advisory board of the Nicotine Science Center of Denmark since 2014. From 2016 to 2018, he served as a member of the Scientific Committee of the Innovative Medicines Initiative (IMI) of the European Union in Brussels, giving advice on scientific priorities to be included in the Strategic Research Agenda for Horizon 2020.

Andreas Bernkop-Schnürch is the founder of Thiomatrix Forschungs- und Beratungs GmbH, Mucobiomer Biotechnologische Forschungs- und Entwicklungs GmbH (now part of the Croma-Pharma GmbH) and Green River Polymers Forschungs und Entwicklungs GmbH. He has been listed as a Highly Cited Researcher of the Institute for Scientific Information since 2022. Provided by Wikipedia